412 related articles for article (PubMed ID: 2498381)
1. The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum.
McLachlan RI; Cohen NL; Vale WW; Rivier JE; Burger HG; Bremner WJ; Soules MR
J Clin Endocrinol Metab; 1989 Jun; 68(6):1078-85. PubMed ID: 2498381
[TBL] [Abstract][Full Text] [Related]
2. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
Roseff SJ; Bangah ML; Kettel LM; Vale W; Rivier J; Burger HG; Yen SS
J Clin Endocrinol Metab; 1989 Nov; 69(5):1033-9. PubMed ID: 2507568
[TBL] [Abstract][Full Text] [Related]
4. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH.
Dubourdieu S; Charbonnel B; D'Acremont MF; Carreau S; Spitz IM; Bouchard P
J Clin Endocrinol Metab; 1994 Feb; 78(2):343-7. PubMed ID: 8106622
[TBL] [Abstract][Full Text] [Related]
5. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
[TBL] [Abstract][Full Text] [Related]
6. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists.
Hall JE; Whitcomb RW; Rivier JE; Vale WW; Crowley WF
J Clin Endocrinol Metab; 1990 Feb; 70(2):328-35. PubMed ID: 2105329
[TBL] [Abstract][Full Text] [Related]
8. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.
Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ
J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men.
Bagatell CJ; McLachlan RI; de Kretser DM; Burger HG; Vale WW; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1989 Jul; 69(1):43-8. PubMed ID: 2499592
[TBL] [Abstract][Full Text] [Related]
10. Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist.
Hall JE; Brodie TD; Badger TM; Rivier J; Vale W; Conn PM; Schoenfeld D; Crowley WF
J Clin Endocrinol Metab; 1988 Sep; 67(3):524-31. PubMed ID: 3137243
[TBL] [Abstract][Full Text] [Related]
11. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human.
Hall JE; Bhatta N; Adams JM; Rivier JE; Vale WW; Crowley WF
J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489
[TBL] [Abstract][Full Text] [Related]
12. The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe.
Mais V; Kazer RR; Cetel NS; Rivier J; Vale W; Yen SS
J Clin Endocrinol Metab; 1986 Jun; 62(6):1250-5. PubMed ID: 3084538
[TBL] [Abstract][Full Text] [Related]
13. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
Kettel LM; Roseff SJ; Chiu TC; Bangah ML; Vale W; Rivier J; Burger HG; Yen SS
J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant inhibin on gonadotropin secretion during proestrus and estrus in the rat.
Rivier C; Schwall R; Mason A; Burton L; Vale W
Endocrinology; 1991 May; 128(5):2223-8. PubMed ID: 1902163
[TBL] [Abstract][Full Text] [Related]
15. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
[TBL] [Abstract][Full Text] [Related]
16. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
17. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of circulating concentrations of gonadotropins and ovarian hormones throughout the menstrual cycle in the bonnet monkey: role of inhibin A in the regulation of follicle-stimulating hormone secretion.
Suresh PS; Medhamurthy R
Am J Primatol; 2009 Oct; 71(10):817-24. PubMed ID: 19452529
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
[TBL] [Abstract][Full Text] [Related]
20. Control of progesterone and inhibin secretion during the luteal phase in the macaque.
Smith KB; Fraser HM
J Endocrinol; 1991 Jan; 128(1):107-13. PubMed ID: 1900319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
